Equillium Inc (EQ) concluded trading on Wednesday at a closing price of $0.39, with 12.64 million shares of worth about $4.93 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -47.38% during that period and on June 11, 2025 the price saw a gain of about 10.10%. Currently the company’s common shares owned by public are about 35.72M shares, out of which, 17.58M shares are available for trading.
Stock saw a price change of 4.61% in past 5 days and over the past one month there was a price change of 0.52%. Year-to-date (YTD), EQ shares are showing a performance of -48.41% which decreased to -51.81% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.34 but also hit the highest price of $1.50 during that period. The average intraday trading volume for Equillium Inc shares is 105.66K. The stock is currently trading 2.16% above its 20-day simple moving average (SMA20), while that difference is down -7.46% for SMA50 and it goes to -45.75% lower than SMA200.
Equillium Inc (NASDAQ: EQ) currently have 35.72M outstanding shares and institutions hold larger chunk of about 5.11% of that.
The stock has a current market capitalization of $13.79M and its 3Y-monthly beta is at 1.93. It has posted earnings per share of -$0.39 in the same period. It has Quick Ratio of 2.70 while making debt-to-equity ratio of 0.03. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for EQ, volatility over the week remained 7.52% while standing at 5.40% over the month.
Stock’s fiscal year EPS is expected to drop by -269.57% while it is estimated to decrease by -28.24% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Leerink Partners on March 28, 2025 offering a Market perform rating for the stock and assigned a target price range of between $3 and $1 to it. Coverage by Stifel stated Equillium Inc (EQ) stock as a Buy in their note to investors on October 29, 2021, suggesting a price target of $12 for the stock. On September 15, 2021, Cantor Fitzgerald Initiated their recommendations, while on July 14, 2020, H.C. Wainwright Reiterated their ratings for the stock with a price target of $24. Stock get a Buy rating from Stifel on July 10, 2020.